Methamphetamine and injecting drug use cohort studies: MIXMAX

MIXMAX is the largest active cohort study of people who use drugs in Australia. It combines 2 pre-existing studies:

SuperMIX – the largest and longest running cohort study of people who inject drugs in Australia (2008 onwards).
VMAX – a cohort study determining patterns of methamphetamine use and harm in metropolitan and rural Victoria. The study is focused on methamphetamine smoking (2016 onwards).

The 2 studies have combined to establish new evidence on the harms of injecting drug use and methamphetamine use, and the effectiveness health programs and treatments to address them.

A cohort study is a research method where scientists follow a group of people over time to see how certain things, like habits or exposures, affect their health.

Injecting drug use in Melbourne: SuperMIX cohort study

PROJECT

Methamphetamine use in Melbourne and rural Victoria: the VMAX cohort study

PROJECT

Published research

Publications

VIEW ALL RESEARCH

The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia.

Rathnayake K, Agius PA, Ward B, Hickman M, Maher L, Stoové M, Doyle JS, Hellard M, Wilkinson A, Quinn B, Crawford S, Sutton K, Dietze P

Addiction (Abingdon, England)
02 Apr 2023

COVID-19

Prevalence and Correlates of Panic Attacks Among People Who Primarily Smoke Methamphetamine

Hine R, Ward B, Kippen R, Sutton K, Duncan Z, Quinn B, Powell A, Dietze P

24 Mar 2023

Alcohol and Other Drugs

The prevalence of drug driving and being caught for a drug driving offense among community-recruited people who use methamphetamine in metropolitan and rural Victoria, Australia.

Nightingale C, Kippen R, Ward B, Stoove M, Quinn B, Sutton K, Dietze P

Traffic injury prevention
20 Jan 2023

Interventions to support parents who use methamphetamine: A narrative systematic review.

Ward B, Moller C, Maybery D, Weimande B, Krause M, Dietze P, Harvey P, Kippen R, McCormick F, Lloyd-Jones M, Reupert A

01 Aug 2022

Alcohol and Other Drugs

Health Service Use for Mental Health Reasons in a Cohort of People Who Use Methamphetamine Experiencing Moderate to Severe Anxiety or Depression.

Duncan Z, Kippen R, Sutton K, Ward B, Quinn B, Dietze P

25 Jul 2022

Alcohol and Other Drugs

Level and correlates of social support in a community-based sample of Australians who primarily smoke methamphetamine.

Leach MJ, Ward B, Kippen R, Quinn B, Agius PA, Sutton K, Peterson J, Dietze PM

Health & social care in the community
14 Jul 2022

Qualitative understandings of access to primary care services for consumers who use methamphetamine.

Ward B, Lane R, Quinn B, Russell G

Australian journal of general practice
24 Nov 2021

Correlates of anxiety and depression in a community cohort of people who smoke methamphetamine.

Duncan Z, Kippen R, Sutton K, Ward B, Agius PA, Quinn B, Dietze P

The Australian and New Zealand journal of psychiatry
24 Sep 2021

A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence.

Quinn B, Ward B, Agius PA, Jenkinson R, Hickman M, Sutton K, Hall C, McKetin R, Farrell M, Cossar R, Dietze PM

Drug and alcohol review
11 Nov 2020

Parent and child co-resident status among an Australian community-based sample of methamphetamine smokers.

Ward B, Kippen R, Reupert A, Maybery D, Agius PA, Quinn B, Jenkinson R, Hickman M, Sutton K, Goldsmith R, Dietze PM

Drug and alcohol review
08 Sep 2020

More information

For more information, please contact paul.dietze@burnet.edu.au.

Funding partners

National Health and Medical Research Council (NHMRC). Grant ID: 2023690.

Partners and collaborators

Monash Rural Health (Bernadette Ward)

British Columbia Centre on Substance Use (Thomas Kerr)

Curtin University (Jocelyn Jones, Samantha Colledge-Frisby, Michael Curtis)

Deakin University (Paul Agius)

University of Bristol (Matthew Hickman)

Monash University School of Public Health and Preventive Medicine (James Trauer)

UNSW Kirby Institute, University of New South Wales (Lisa Maher)

Alfred Health (Andrew Stewardson)

Harm Reduction Victoria (Sione Crawford)

Royal Melbourne Hospital (Nicholas Clark)

Burnet project team

Professor Paul Dietze

PROGRAM DIRECTOR, DISEASE ELIMINATION; PROFESSOR AND PROGRAM LEADER, NATIONAL DRUG RESEARCH INSTITUTE (NDRI)

Professor Paul Dietze is one of Australia's leading alcohol and other drug epidemiologists...

Troy Combo

PROGRAM MANAGER, ABORIGINAL HEALTH PLAN, EC AUSTRALIA

Troy is a Bundjalung man from the Northern NSW and is a highly regarded leader in Aboriginal health....

Filip Djordjevic

RESEARCH ASSISTANT

Filip joined Burnet Institute in 2019 on the Disease Elimination and Behaviours and Health Risks pro...

Professor Joseph (Joe) Doyle

DEPUTY PROGRAM DIRECTOR, DISEASE ELIMINATION; CO-HEAD, INFECTIOUS DISEASES CLINICAL RESEARCH; PRESIDENT, HEPATITIS AUSTRALIA; NHMRC CLINICAL RESEARCH FELLOW

Professor Doyle is a clinician-researcher and dual-trained infectious diseases and public health phy...